Franz Schuler
Impact in
- Pharmaceutical Science top 2%
- Fluorine in Organic Chemistry
- Organic Chemistry top 5%
- Synthesis and Catalytic Reactions
- Asymmetric Synthesis and Catalysis
- Catalytic C–H Functionalization Methods
Papers in
- Oncology 9
- Drug Transport and Resistance Mechanisms 7
-
- Receptor Mechanisms and Signaling 2
- Co-authors
- Holger Fischer (7 shared papers)Björn Wagner (5 shared papers)Klaus Müller (4 shared papers)Erick M. Carreira (4 shared papers)Mark Rogers‐Evans (4 shared papers)Georg Wuitschik (3 shared papers)Liudmila Polonchuk (5 shared papers)I. Parrilla (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (5 papers)Drug Metabolism and Disposition (2 papers)Angewandte Chemie International Edition (2 papers)Molecular Pharmaceutics (2 papers)Drug Discovery Today (2 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Franz Schuler
31 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 107
- Pharmaceutical Science 175
- Organic Chemistry 717
- Pharmacology 113
- Process Chemistry and Technology 27
- Molecular Biology 542
Countries citing papers authored by Franz Schuler
This map shows the geographic impact of Franz Schuler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franz Schuler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franz Schuler more than expected).
Fields of papers citing papers by Franz Schuler
This network shows the impact of papers produced by Franz Schuler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franz Schuler. The network helps show where Franz Schuler may publish in the future.
Co-authors
The 25 scholars most cited alongside Franz Schuler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 333 | |
| 2 | 2006 | 210 | |
| 3 | 2010 | 209 | |
| 4 | 2019 | 157 | |
| 5 | 2017 | 95 | |
| 6 | 2017 | 69 | |
| 7 | 2000 | 53 | |
| 8 | 2016 | 51 | |
| 9 | 2018 | 45 | |
| 10 | 2015 | 43 | |
| 11 | 2015 | 42 | |
| 12 | 2016 | 34 | |
| 13 | 2019 | 33 | |
| 14 | 2018 | 32 | |
| 15 | 2018 | 27 | |
| 16 | 2013 | 25 | |
| 17 | 2024 | 20 | |
| 18 | 2017 | 19 | |
| 19 | 2012 | 15 | |
| 20 | 2017 | 14 |
About Franz Schuler
Franz Schuler is a scholar working on Oncology, Molecular Biology, Organic Chemistry, Radiology, Nuclear Medicine and Imaging and Pharmaceutical Science, having authored 32 papers that have together received 1.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Synthesis and Catalytic Reactions (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Cardiac electrophysiology and arrhythmias (2 papers), Receptor Mechanisms and Signaling (2 papers), Lanthanide and Transition Metal Complexes (2 papers) and Fluorine in Organic Chemistry (2 papers). The work is most often cited by research in Pharmaceutical Science (175 citations), Organic Chemistry (717 citations), Pharmacology (113 citations), Process Chemistry and Technology (27 citations) and Molecular Biology (542 citations). Franz Schuler has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Holger Fischer, Björn Wagner, Klaus Müller, Erick M. Carreira, Mark Rogers‐Evans, Georg Wuitschik, Liudmila Polonchuk, I. Parrilla, Johannes A. Burkhard and Christoph Funk. Their work appears in journals such as Journal of Medicinal Chemistry, Drug Metabolism and Disposition, Angewandte Chemie International Edition, Molecular Pharmaceutics and Drug Discovery Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.